BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9611389)

  • 1. What is the cost of onychomycosis?
    Sinclair R
    Australas J Dermatol; 1998 May; 39(2):131-2. PubMed ID: 9611389
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment costs of three nail lacquers used in onychomycosis.
    Marty JP; Lambert J; Jäckel A; Adjadj L
    J Dermatolog Treat; 2005; 16(5-6):299-307. PubMed ID: 16428149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
    Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
    Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group.
    Arikian SR; Einarson TR; Kobelt-Nguyen G; Schubert F
    Br J Dermatol; 1994 Apr; 130 Suppl 43():35-44. PubMed ID: 8186141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of usage and estimation of cost for efinaconazole 10% topical solution in the treatment of onychomycosis.
    Lin K; Lipner SR
    J Am Acad Dermatol; 2020 Jul; 83(1):227-228. PubMed ID: 31712169
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of onychomycosis].
    Suhonen R; Karvonen J
    Duodecim; 1998; 22(114):2343-50. PubMed ID: 11757097
    [No Abstract]   [Full Text] [Related]  

  • 7. Itraconazole concentrations of fingernails and toenails of patients with tinea unguium.
    Maeda M
    J Dermatol; 2008 May; 35(5):314-5. PubMed ID: 18477237
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of toenail onychomycosis. Prescribing terbinafine to every patient with the condition would be expensive.
    Rose P; Wilson T
    BMJ; 1999 Oct; 319(7218):1197. PubMed ID: 10610152
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of onychomycosis on quality of life.
    Drake LA; Scher RK; Smith EB; Faich GA; Smith SL; Hong JJ; Stiller MJ
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):702-4. PubMed ID: 9591814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New effective methods of onychomycosis therapy in servicemen].
    Tarasenko GN; Patronov IV; Kuz'mina IuV; Tarasenko IuG
    Voen Med Zh; 2006 Jun; 327(6):13-6. PubMed ID: 16898287
    [No Abstract]   [Full Text] [Related]  

  • 11. [New treatments of onychomycoses].
    Baran R
    Ann Dermatol Venereol; 1992; 119(3):227-31. PubMed ID: 1318667
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful eradication of Scytalidium dimidiatum-induced ungual and cutaneous infection with voriconazole.
    Spriet I; Lambrecht C; Lagrou K; Verhamme B
    Eur J Dermatol; 2012; 22(2):197-9. PubMed ID: 22377678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies for onychomycosis: a review.
    Gupta AK; Tu LQ
    Dermatol Clin; 2006 Jul; 24(3):375-9. PubMed ID: 16798436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What causes toenail fungus and how can I get rid of it?
    Johns Hopkins Med Lett Health After 50; 2003 Sep; 15(7):8. PubMed ID: 14533595
    [No Abstract]   [Full Text] [Related]  

  • 16. [A clinical trial and the prospects for the Orungal therapy of onychomycoses].
    Tarasenko GN; Patronov IV; Tarasenko IuG
    Voen Med Zh; 1999 Jun; 320(6):37-9. PubMed ID: 10439713
    [No Abstract]   [Full Text] [Related]  

  • 17. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
    Gerasimchuk EV; Gerasimov VV; Molchanov BA
    Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective.
    Einarson TR; Arikian SR; Shear NH
    Br J Dermatol; 1994 Apr; 130 Suppl 43():32-4. PubMed ID: 8186140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries. Which oral antifungal is best for toenail onychomycosis?
    Hinojosa JR; Hitchcock K; Rodriguez JE
    J Fam Pract; 2007 Jul; 56(7):581-2. PubMed ID: 17605954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rational therapeutic strategies in onychomycoses. When topical, when systemic treatment?].
    Effendy I
    Fortschr Med; 1993 Mar; 111(9):147-9. PubMed ID: 8486326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.